Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Risk management and pharmacovigilance in non-medical prescribing decisions

Risk management and pharmacovigilance in non-medical prescribing decisions This is the final article in a series of three in which the authors have discussed non-medical prescribing in the context of the law and explored how it applies to the field of aesthetic medicine. The aim of this article is to educate aesthetic practitioners about minimising risks associated with prescribing. The authors will consider the elements of prescribing risk, discuss common drug errors and outline the main types of adverse drug reactions. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Aesthetic Nursing Mark Allen Group

Risk management and pharmacovigilance in non-medical prescribing decisions

Journal of Aesthetic Nursing , Volume 6 (7): 5 – Sep 2, 2017

Loading next page...
 
/lp/mark-allen-group/risk-management-and-pharmacovigilance-in-non-medical-prescribing-AW3gIKYN2K

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Mark Allen Group
Copyright
Copyright © 2017 MA Healthcare Limited
ISSN
2050-3717
eISSN
2052-2878
DOI
10.12968/joan.2017.6.7.351
Publisher site
See Article on Publisher Site

Abstract

This is the final article in a series of three in which the authors have discussed non-medical prescribing in the context of the law and explored how it applies to the field of aesthetic medicine. The aim of this article is to educate aesthetic practitioners about minimising risks associated with prescribing. The authors will consider the elements of prescribing risk, discuss common drug errors and outline the main types of adverse drug reactions.

Journal

Journal of Aesthetic NursingMark Allen Group

Published: Sep 2, 2017

There are no references for this article.